| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Talc | 7 | 2020 | 47 | 3.920 |
Why?
|
| Inhalation Exposure | 19 | 2020 | 443 | 3.590 |
Why?
|
| Air Pollutants | 35 | 2020 | 2817 | 2.950 |
Why?
|
| Particulate Matter | 21 | 2020 | 2530 | 2.150 |
Why?
|
| Power Plants | 8 | 2011 | 119 | 2.130 |
Why?
|
| Microscopy, Electron, Scanning | 7 | 2020 | 964 | 1.750 |
Why?
|
| Vehicle Emissions | 6 | 2019 | 665 | 1.610 |
Why?
|
| Environmental Monitoring | 11 | 2015 | 1414 | 1.200 |
Why?
|
| Environmental Exposure | 12 | 2015 | 4234 | 1.130 |
Why?
|
| Microscopy, Polarization | 4 | 2019 | 88 | 1.060 |
Why?
|
| Ovary | 2 | 2020 | 981 | 1.000 |
Why?
|
| Lymph Nodes | 7 | 2020 | 3474 | 0.900 |
Why?
|
| Spectrometry, X-Ray Emission | 3 | 2020 | 144 | 0.880 |
Why?
|
| Mesothelioma | 12 | 2018 | 818 | 0.820 |
Why?
|
| Aerosols | 18 | 2020 | 625 | 0.790 |
Why?
|
| Pleural Neoplasms | 11 | 2013 | 607 | 0.790 |
Why?
|
| Macrophages | 22 | 2020 | 5655 | 0.780 |
Why?
|
| Respiration | 4 | 2012 | 1653 | 0.780 |
Why?
|
| Lung | 38 | 2020 | 9856 | 0.770 |
Why?
|
| Magnesium Silicates | 1 | 2020 | 1 | 0.760 |
Why?
|
| Rats, Sprague-Dawley | 26 | 2020 | 8301 | 0.740 |
Why?
|
| Subcutaneous Tissue | 2 | 2010 | 135 | 0.700 |
Why?
|
| Omentum | 1 | 2020 | 170 | 0.700 |
Why?
|
| Toxicity Tests | 8 | 2011 | 121 | 0.690 |
Why?
|
| Particle Size | 20 | 2020 | 1642 | 0.690 |
Why?
|
| Dogs | 19 | 2015 | 3912 | 0.680 |
Why?
|
| Genitalia, Female | 1 | 2019 | 146 | 0.650 |
Why?
|
| Perineum | 1 | 2019 | 211 | 0.630 |
Why?
|
| Pelvis | 2 | 2019 | 730 | 0.630 |
Why?
|
| Baroreflex | 2 | 2017 | 146 | 0.630 |
Why?
|
| Ovarian Neoplasms | 5 | 2020 | 4838 | 0.620 |
Why?
|
| Coal | 8 | 2011 | 119 | 0.620 |
Why?
|
| Neutrophils | 9 | 2020 | 3719 | 0.620 |
Why?
|
| Autonomic Nervous System | 4 | 2018 | 671 | 0.610 |
Why?
|
| Heart | 10 | 2019 | 4467 | 0.600 |
Why?
|
| Pleura | 2 | 2018 | 235 | 0.600 |
Why?
|
| Air Pollution | 6 | 2015 | 2286 | 0.600 |
Why?
|
| Pneumonia | 10 | 2019 | 2133 | 0.570 |
Why?
|
| Bronchoalveolar Lavage Fluid | 14 | 2020 | 768 | 0.560 |
Why?
|
| Arrhythmias, Cardiac | 4 | 2020 | 2268 | 0.550 |
Why?
|
| Catheters, Indwelling | 3 | 2007 | 426 | 0.550 |
Why?
|
| Asbestos | 6 | 2013 | 251 | 0.550 |
Why?
|
| Foreign Bodies | 2 | 2010 | 399 | 0.540 |
Why?
|
| Rats | 36 | 2019 | 24260 | 0.520 |
Why?
|
| Macrophages, Alveolar | 10 | 2001 | 407 | 0.520 |
Why?
|
| Foreign-Body Reaction | 3 | 2010 | 157 | 0.480 |
Why?
|
| Reactive Oxygen Species | 5 | 2019 | 2077 | 0.470 |
Why?
|
| Pulmonary Alveoli | 17 | 2014 | 675 | 0.460 |
Why?
|
| Carbon Monoxide | 3 | 2006 | 531 | 0.430 |
Why?
|
| Prostheses and Implants | 2 | 2010 | 1387 | 0.430 |
Why?
|
| Microspheres | 4 | 2010 | 777 | 0.420 |
Why?
|
| Volatile Organic Compounds | 2 | 2012 | 81 | 0.410 |
Why?
|
| Animals | 89 | 2020 | 168757 | 0.380 |
Why?
|
| Respiratory Tract Diseases | 1 | 2015 | 722 | 0.350 |
Why?
|
| Bronchitis | 4 | 2000 | 201 | 0.340 |
Why?
|
| Lung Diseases | 9 | 2009 | 1886 | 0.340 |
Why?
|
| Bayes Theorem | 3 | 2015 | 2309 | 0.300 |
Why?
|
| Heart Rate | 7 | 2020 | 4091 | 0.300 |
Why?
|
| Surgical Stomas | 1 | 2007 | 43 | 0.300 |
Why?
|
| Cricetinae | 20 | 2020 | 2472 | 0.300 |
Why?
|
| Infusions, Intra-Arterial | 1 | 2007 | 234 | 0.300 |
Why?
|
| Respiration Disorders | 1 | 2010 | 371 | 0.280 |
Why?
|
| Myocardial Ischemia | 6 | 2008 | 2148 | 0.280 |
Why?
|
| Myocardial Infarction | 5 | 2011 | 11727 | 0.280 |
Why?
|
| Bronchitis, Chronic | 2 | 2002 | 62 | 0.260 |
Why?
|
| Oxidative Stress | 8 | 2019 | 3086 | 0.260 |
Why?
|
| Carbon | 3 | 2006 | 687 | 0.260 |
Why?
|
| Statistics as Topic | 1 | 2011 | 2373 | 0.250 |
Why?
|
| Disease Models, Animal | 13 | 2017 | 18029 | 0.240 |
Why?
|
| Titanium | 2 | 2010 | 494 | 0.230 |
Why?
|
| Tracheostomy | 1 | 2007 | 401 | 0.230 |
Why?
|
| Biometry | 1 | 2006 | 558 | 0.230 |
Why?
|
| Trachea | 5 | 2007 | 1076 | 0.220 |
Why?
|
| Dust | 3 | 2020 | 482 | 0.220 |
Why?
|
| Arteries | 2 | 2007 | 1119 | 0.220 |
Why?
|
| Leukocyte Count | 5 | 2019 | 1588 | 0.220 |
Why?
|
| Disease Susceptibility | 1 | 2010 | 1782 | 0.220 |
Why?
|
| Pneumonia, Pneumocystis | 1 | 2004 | 249 | 0.220 |
Why?
|
| United States Environmental Protection Agency | 4 | 2015 | 139 | 0.210 |
Why?
|
| Coronary Circulation | 1 | 2008 | 1572 | 0.210 |
Why?
|
| Atmosphere Exposure Chambers | 5 | 2011 | 50 | 0.210 |
Why?
|
| Models, Theoretical | 5 | 2011 | 3589 | 0.210 |
Why?
|
| Vanadium | 2 | 1999 | 53 | 0.210 |
Why?
|
| Antigens, Surface | 9 | 1989 | 1663 | 0.210 |
Why?
|
| Carcinoma, Papillary | 1 | 2007 | 783 | 0.210 |
Why?
|
| Artificial Intelligence | 1 | 2015 | 2214 | 0.200 |
Why?
|
| Consciousness | 1 | 2007 | 572 | 0.200 |
Why?
|
| Regional Blood Flow | 3 | 2010 | 1525 | 0.200 |
Why?
|
| Opportunistic Infections | 1 | 2004 | 389 | 0.190 |
Why?
|
| Electrocardiography | 5 | 2020 | 6442 | 0.190 |
Why?
|
| Monokines | 7 | 2001 | 75 | 0.190 |
Why?
|
| Quartz | 1 | 2020 | 24 | 0.190 |
Why?
|
| Lung Neoplasms | 13 | 2018 | 13102 | 0.180 |
Why?
|
| Heart Diseases | 2 | 2006 | 2788 | 0.180 |
Why?
|
| Gasoline | 1 | 2019 | 51 | 0.180 |
Why?
|
| Vasoconstriction | 1 | 2002 | 597 | 0.180 |
Why?
|
| Respiratory Function Tests | 5 | 2011 | 1616 | 0.180 |
Why?
|
| Male | 80 | 2020 | 350118 | 0.170 |
Why?
|
| Silicones | 3 | 2010 | 250 | 0.170 |
Why?
|
| Silicon Dioxide | 1 | 2020 | 213 | 0.170 |
Why?
|
| Respiratory Burst | 1 | 1999 | 114 | 0.170 |
Why?
|
| Phagocytosis | 10 | 2001 | 1539 | 0.170 |
Why?
|
| Aorta | 1 | 2006 | 2061 | 0.160 |
Why?
|
| Pleurodesis | 1 | 2018 | 41 | 0.160 |
Why?
|
| Pulmonary Artery | 2 | 2006 | 1912 | 0.160 |
Why?
|
| Adenocarcinoma, Clear Cell | 1 | 2019 | 221 | 0.160 |
Why?
|
| Thoracostomy | 1 | 2018 | 72 | 0.150 |
Why?
|
| Administration, Inhalation | 4 | 2011 | 1105 | 0.150 |
Why?
|
| Lymphocytes | 4 | 2002 | 2617 | 0.150 |
Why?
|
| Phagocytes | 1 | 2019 | 297 | 0.150 |
Why?
|
| Metals | 4 | 2014 | 719 | 0.150 |
Why?
|
| Models, Animal | 4 | 2007 | 2171 | 0.150 |
Why?
|
| Surface Properties | 1 | 2020 | 1184 | 0.150 |
Why?
|
| Sulfites | 2 | 1994 | 79 | 0.150 |
Why?
|
| Sympathetic Nervous System | 1 | 2020 | 514 | 0.150 |
Why?
|
| Pulmonary Fibrosis | 8 | 1985 | 530 | 0.150 |
Why?
|
| Carcinoma, Endometrioid | 1 | 2019 | 271 | 0.140 |
Why?
|
| Myocardium | 8 | 2011 | 4776 | 0.140 |
Why?
|
| Mesocricetus | 14 | 1993 | 252 | 0.140 |
Why?
|
| Endocytosis | 2 | 2001 | 985 | 0.140 |
Why?
|
| Peritoneal Neoplasms | 2 | 2018 | 665 | 0.140 |
Why?
|
| Ventricular Premature Complexes | 2 | 2011 | 111 | 0.140 |
Why?
|
| Female | 56 | 2020 | 380194 | 0.140 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2000 | 640 | 0.140 |
Why?
|
| Lymphangioleiomyomatosis | 1 | 2018 | 210 | 0.130 |
Why?
|
| Deoxycytidine | 1 | 2000 | 826 | 0.130 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2019 | 450 | 0.130 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2018 | 256 | 0.130 |
Why?
|
| Uterus | 1 | 2019 | 711 | 0.130 |
Why?
|
| Blood Pressure | 2 | 2008 | 8554 | 0.130 |
Why?
|
| Osmium Tetroxide | 1 | 1994 | 3 | 0.130 |
Why?
|
| Stress, Psychological | 1 | 2010 | 4245 | 0.120 |
Why?
|
| Models, Biological | 4 | 2010 | 9583 | 0.120 |
Why?
|
| Microscopy, Electron | 8 | 2001 | 2645 | 0.120 |
Why?
|
| Pneumothorax | 1 | 2018 | 379 | 0.120 |
Why?
|
| Hazardous Substances | 1 | 2015 | 149 | 0.120 |
Why?
|
| Heart Conduction System | 1 | 2020 | 1047 | 0.120 |
Why?
|
| Cell Count | 5 | 2011 | 1856 | 0.120 |
Why?
|
| Carcinogens | 2 | 2013 | 466 | 0.110 |
Why?
|
| NADH, NADPH Oxidoreductases | 1 | 1993 | 93 | 0.110 |
Why?
|
| Humans | 67 | 2020 | 744343 | 0.110 |
Why?
|
| DNA Methylation | 7 | 2012 | 4286 | 0.110 |
Why?
|
| Ethanol | 1 | 2019 | 1342 | 0.110 |
Why?
|
| Bile Acids and Salts | 1 | 1994 | 367 | 0.100 |
Why?
|
| Translocation, Genetic | 1 | 2018 | 1420 | 0.100 |
Why?
|
| Hepatocyte Nuclear Factor 3-beta | 1 | 2012 | 67 | 0.100 |
Why?
|
| Hemodynamics | 2 | 2020 | 4199 | 0.100 |
Why?
|
| Plethysmography, Whole Body | 1 | 2011 | 24 | 0.100 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2000 | 808 | 0.100 |
Why?
|
| Blood Cell Count | 1 | 2012 | 403 | 0.100 |
Why?
|
| Photochemistry | 1 | 2011 | 238 | 0.100 |
Why?
|
| Bronchi | 4 | 2011 | 840 | 0.090 |
Why?
|
| Sirolimus | 1 | 2018 | 1564 | 0.090 |
Why?
|
| Postoperative Care | 2 | 2007 | 1486 | 0.090 |
Why?
|
| Environmental Pollutants | 2 | 2014 | 1179 | 0.090 |
Why?
|
| GPI-Linked Proteins | 1 | 2011 | 434 | 0.090 |
Why?
|
| Leiomyoma | 1 | 2015 | 730 | 0.090 |
Why?
|
| Plethysmography | 1 | 2010 | 180 | 0.090 |
Why?
|
| Electron Probe Microanalysis | 2 | 2007 | 33 | 0.090 |
Why?
|
| Environmental Health | 2 | 2014 | 278 | 0.090 |
Why?
|
| Occupational Exposure | 3 | 2006 | 1796 | 0.090 |
Why?
|
| Respiratory System | 2 | 2007 | 557 | 0.080 |
Why?
|
| Lymphoma, Non-Hodgkin | 2 | 2013 | 1381 | 0.080 |
Why?
|
| Respiratory Rate | 1 | 2010 | 162 | 0.080 |
Why?
|
| Nanostructures | 1 | 2014 | 551 | 0.080 |
Why?
|
| Epithelial Cells | 1 | 2001 | 3690 | 0.080 |
Why?
|
| Models, Molecular | 1 | 2018 | 5456 | 0.080 |
Why?
|
| Sulfones | 1 | 2010 | 437 | 0.080 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 5 | 2012 | 5221 | 0.080 |
Why?
|
| Liver | 3 | 2007 | 7474 | 0.080 |
Why?
|
| Aged | 19 | 2020 | 163280 | 0.080 |
Why?
|
| Body Burden | 1 | 2008 | 158 | 0.080 |
Why?
|
| Hydrogen Peroxide | 5 | 1999 | 731 | 0.080 |
Why?
|
| Cells, Cultured | 4 | 2020 | 19229 | 0.070 |
Why?
|
| Cytokines | 4 | 1996 | 7322 | 0.070 |
Why?
|
| Middle Aged | 28 | 2020 | 213383 | 0.070 |
Why?
|
| Metal Nanoparticles | 1 | 2011 | 405 | 0.070 |
Why?
|
| Cellulose | 2 | 1990 | 121 | 0.070 |
Why?
|
| Immune Sera | 2 | 1984 | 641 | 0.070 |
Why?
|
| Histocytochemistry | 5 | 1989 | 719 | 0.070 |
Why?
|
| Iron | 2 | 1994 | 1774 | 0.070 |
Why?
|
| Acetylcysteine | 3 | 2004 | 272 | 0.070 |
Why?
|
| Volcanic Eruptions | 1 | 2006 | 17 | 0.070 |
Why?
|
| Neoplasm Staging | 6 | 2011 | 11031 | 0.070 |
Why?
|
| Macrophage Inflammatory Proteins | 4 | 2001 | 122 | 0.070 |
Why?
|
| Cardiomyopathies | 1 | 2018 | 1912 | 0.070 |
Why?
|
| Chemokine CXCL2 | 5 | 2001 | 111 | 0.070 |
Why?
|
| Uterine Neoplasms | 1 | 2015 | 1513 | 0.070 |
Why?
|
| Epigenesis, Genetic | 4 | 2012 | 3647 | 0.070 |
Why?
|
| Cardiovascular Diseases | 2 | 2003 | 15165 | 0.070 |
Why?
|
| Granuloma | 2 | 2004 | 319 | 0.070 |
Why?
|
| Pneumonectomy | 2 | 2011 | 1094 | 0.070 |
Why?
|
| Hodgkin Disease | 1 | 2013 | 1415 | 0.070 |
Why?
|
| Pulmonary Emphysema | 2 | 1990 | 672 | 0.070 |
Why?
|
| Bleomycin | 6 | 1991 | 512 | 0.070 |
Why?
|
| Pericardium | 2 | 2007 | 667 | 0.060 |
Why?
|
| Tracheal Stenosis | 1 | 2007 | 226 | 0.060 |
Why?
|
| Coronary Vessels | 2 | 2007 | 3107 | 0.060 |
Why?
|
| Tetradecanoylphorbol Acetate | 4 | 1994 | 821 | 0.060 |
Why?
|
| Data Interpretation, Statistical | 1 | 2015 | 2716 | 0.060 |
Why?
|
| Ammonium Sulfate | 2 | 1984 | 29 | 0.060 |
Why?
|
| Thoracotomy | 1 | 2006 | 363 | 0.060 |
Why?
|
| Cardiac Complexes, Premature | 1 | 2004 | 64 | 0.060 |
Why?
|
| Inflammation | 7 | 2007 | 10638 | 0.060 |
Why?
|
| Bronchoalveolar Lavage | 2 | 2004 | 120 | 0.060 |
Why?
|
| Down-Regulation | 1 | 2012 | 3002 | 0.060 |
Why?
|
| Benzo(a)pyrene | 1 | 1984 | 26 | 0.060 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2006 | 705 | 0.060 |
Why?
|
| Serratia marcescens | 2 | 1982 | 45 | 0.060 |
Why?
|
| Tumor Necrosis Factor-alpha | 4 | 2010 | 4420 | 0.060 |
Why?
|
| Adenocarcinoma | 3 | 2012 | 6364 | 0.060 |
Why?
|
| DNA, Neoplasm | 2 | 2008 | 1758 | 0.060 |
Why?
|
| Chemistry, Physical | 1 | 2003 | 156 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 3 | 2012 | 5867 | 0.060 |
Why?
|
| Chemical Phenomena | 1 | 2003 | 518 | 0.060 |
Why?
|
| Time Factors | 13 | 2010 | 40075 | 0.060 |
Why?
|
| Urban Health | 2 | 2011 | 547 | 0.060 |
Why?
|
| Polymers | 1 | 2010 | 1621 | 0.060 |
Why?
|
| Cross-Over Studies | 1 | 2008 | 2029 | 0.060 |
Why?
|
| Protective Agents | 1 | 2004 | 156 | 0.050 |
Why?
|
| Pilot Projects | 3 | 2012 | 8324 | 0.050 |
Why?
|
| Lymphokines | 1 | 1986 | 949 | 0.050 |
Why?
|
| Dog Diseases | 1 | 1983 | 138 | 0.050 |
Why?
|
| Intubation, Intratracheal | 3 | 2007 | 1364 | 0.050 |
Why?
|
| L-Lactate Dehydrogenase | 2 | 2001 | 424 | 0.050 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2002 | 370 | 0.050 |
Why?
|
| Textiles | 1 | 1981 | 46 | 0.050 |
Why?
|
| Computer Simulation | 1 | 2015 | 6196 | 0.050 |
Why?
|
| Cytochalasins | 1 | 2001 | 19 | 0.050 |
Why?
|
| CpG Islands | 3 | 2011 | 1172 | 0.050 |
Why?
|
| Cell Membrane | 4 | 1989 | 3748 | 0.050 |
Why?
|
| Case-Control Studies | 1 | 2019 | 21746 | 0.050 |
Why?
|
| Spleen | 1 | 2007 | 2362 | 0.050 |
Why?
|
| Adenocarcinoma, Bronchiolo-Alveolar | 1 | 2001 | 91 | 0.050 |
Why?
|
| Peritoneum | 1 | 1981 | 228 | 0.050 |
Why?
|
| RNA, Messenger | 7 | 2001 | 13033 | 0.050 |
Why?
|
| Adult | 20 | 2020 | 214055 | 0.050 |
Why?
|
| Sarcoidosis | 1 | 1986 | 506 | 0.050 |
Why?
|
| Polyethylene | 1 | 2001 | 184 | 0.050 |
Why?
|
| Welding | 1 | 2001 | 89 | 0.050 |
Why?
|
| Models, Statistical | 2 | 2014 | 5102 | 0.050 |
Why?
|
| Metals, Heavy | 1 | 2001 | 139 | 0.050 |
Why?
|
| Printing | 1 | 2020 | 46 | 0.050 |
Why?
|
| Heart Neoplasms | 1 | 1983 | 374 | 0.040 |
Why?
|
| Paraffin Embedding | 1 | 2001 | 299 | 0.040 |
Why?
|
| Joint Prosthesis | 1 | 2001 | 258 | 0.040 |
Why?
|
| Cerium | 1 | 1999 | 7 | 0.040 |
Why?
|
| DNA Mutational Analysis | 3 | 2018 | 4186 | 0.040 |
Why?
|
| Receptors, Immunologic | 1 | 1986 | 1423 | 0.040 |
Why?
|
| Tyrphostins | 1 | 1999 | 67 | 0.040 |
Why?
|
| Cell Cycle | 1 | 2008 | 2967 | 0.040 |
Why?
|
| Mice | 9 | 2019 | 81183 | 0.040 |
Why?
|
| Sulfur Compounds | 1 | 1999 | 31 | 0.040 |
Why?
|
| Autoradiography | 2 | 1995 | 745 | 0.040 |
Why?
|
| Brazil | 3 | 2011 | 1270 | 0.040 |
Why?
|
| Ventricular Pressure | 1 | 2020 | 199 | 0.040 |
Why?
|
| Arteriosclerosis | 1 | 2003 | 1092 | 0.040 |
Why?
|
| Thiobarbituric Acid Reactive Substances | 2 | 2011 | 46 | 0.040 |
Why?
|
| Oxidants | 1 | 1999 | 164 | 0.040 |
Why?
|
| Specimen Handling | 1 | 2003 | 694 | 0.040 |
Why?
|
| Risk Factors | 6 | 2018 | 72290 | 0.040 |
Why?
|
| Antioxidants | 2 | 2004 | 1663 | 0.040 |
Why?
|
| United States | 5 | 2015 | 69872 | 0.040 |
Why?
|
| Neoplasms, Experimental | 1 | 1984 | 1276 | 0.040 |
Why?
|
| Gelsolin | 1 | 1999 | 190 | 0.040 |
Why?
|
| Chemokine CCL4 | 4 | 2001 | 128 | 0.040 |
Why?
|
| Linear Models | 1 | 2008 | 5952 | 0.040 |
Why?
|
| C-Reactive Protein | 1 | 2010 | 3778 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2006 | 2751 | 0.040 |
Why?
|
| Opsonin Proteins | 3 | 1993 | 150 | 0.040 |
Why?
|
| Smoking | 2 | 2006 | 8987 | 0.040 |
Why?
|
| Gravitation | 1 | 1997 | 82 | 0.040 |
Why?
|
| Lung Diseases, Fungal | 1 | 2018 | 122 | 0.040 |
Why?
|
| Elephants | 1 | 1997 | 38 | 0.040 |
Why?
|
| Prospective Studies | 3 | 2015 | 53288 | 0.040 |
Why?
|
| Oxygen | 4 | 1994 | 4189 | 0.040 |
Why?
|
| Respiratory Physiological Phenomena | 1 | 1997 | 188 | 0.040 |
Why?
|
| Air Pollutants, Occupational | 1 | 1999 | 408 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2013 | 6538 | 0.040 |
Why?
|
| Sulfur Dioxide | 2 | 2006 | 177 | 0.040 |
Why?
|
| Gene Dosage | 2 | 2012 | 1252 | 0.030 |
Why?
|
| Bile Canaliculi | 1 | 1995 | 11 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 3 | 1989 | 1799 | 0.030 |
Why?
|
| Shock | 1 | 2018 | 318 | 0.030 |
Why?
|
| Mutation | 3 | 2018 | 29786 | 0.030 |
Why?
|
| Aged, 80 and over | 9 | 2018 | 57776 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2019 | 1341 | 0.030 |
Why?
|
| Neoplasm Proteins | 1 | 2008 | 3703 | 0.030 |
Why?
|
| Chemokines | 3 | 1996 | 970 | 0.030 |
Why?
|
| Respiratory Mechanics | 1 | 1999 | 686 | 0.030 |
Why?
|
| Fluconazole | 1 | 1995 | 146 | 0.030 |
Why?
|
| Polytetrafluoroethylene | 1 | 1996 | 233 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 2 | 2001 | 6314 | 0.030 |
Why?
|
| Pneumonia, Bacterial | 1 | 2018 | 316 | 0.030 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 1998 | 675 | 0.030 |
Why?
|
| Cholic Acids | 1 | 1994 | 41 | 0.030 |
Why?
|
| Operating Rooms | 1 | 1981 | 817 | 0.030 |
Why?
|
| Genes, Retinoblastoma | 1 | 1995 | 136 | 0.030 |
Why?
|
| Superoxides | 2 | 1993 | 387 | 0.030 |
Why?
|
| Cholic Acid | 1 | 1994 | 34 | 0.030 |
Why?
|
| Tyrosine | 1 | 1999 | 1461 | 0.030 |
Why?
|
| Intracellular Membranes | 1 | 1995 | 390 | 0.030 |
Why?
|
| Fluorine | 1 | 1994 | 83 | 0.030 |
Why?
|
| Immunity, Cellular | 1 | 2000 | 1607 | 0.030 |
Why?
|
| Cough | 1 | 2018 | 555 | 0.030 |
Why?
|
| Gene Expression Regulation | 3 | 1999 | 12072 | 0.030 |
Why?
|
| Densitometry | 1 | 1994 | 156 | 0.030 |
Why?
|
| Pulmonary Embolism | 2 | 1987 | 2376 | 0.030 |
Why?
|
| Normal Distribution | 1 | 2014 | 280 | 0.030 |
Why?
|
| Zymosan | 1 | 1994 | 124 | 0.030 |
Why?
|
| Spectrophotometry | 1 | 1994 | 313 | 0.030 |
Why?
|
| beta-Alanine | 1 | 1994 | 74 | 0.030 |
Why?
|
| Bone Marrow | 1 | 2004 | 2948 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 6 | 1986 | 9274 | 0.030 |
Why?
|
| Immunohistochemistry | 4 | 2018 | 11366 | 0.030 |
Why?
|
| Cause of Death | 1 | 2003 | 3584 | 0.030 |
Why?
|
| Biostatistics | 1 | 2014 | 162 | 0.030 |
Why?
|
| Tissue Fixation | 1 | 1994 | 241 | 0.030 |
Why?
|
| Chronic Disease | 3 | 1999 | 9146 | 0.030 |
Why?
|
| Biocompatible Materials | 1 | 2001 | 1736 | 0.030 |
Why?
|
| Free Radicals | 1 | 1993 | 237 | 0.030 |
Why?
|
| Receptors, Fc | 2 | 1989 | 541 | 0.030 |
Why?
|
| Bangladesh | 1 | 2014 | 687 | 0.030 |
Why?
|
| Calmodulin | 1 | 1993 | 209 | 0.030 |
Why?
|
| Dactinomycin | 3 | 1999 | 318 | 0.030 |
Why?
|
| Radiation Chimera | 1 | 1972 | 223 | 0.030 |
Why?
|
| Gene Expression | 3 | 2012 | 7799 | 0.030 |
Why?
|
| Research Design | 1 | 2008 | 5987 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 2014 | 898 | 0.030 |
Why?
|
| Epidermis | 1 | 1995 | 528 | 0.030 |
Why?
|
| Blotting, Northern | 3 | 2001 | 1581 | 0.030 |
Why?
|
| Oxides | 2 | 1990 | 405 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1993 | 708 | 0.030 |
Why?
|
| Bronchoconstriction | 1 | 1992 | 143 | 0.030 |
Why?
|
| Tissue Distribution | 2 | 1994 | 2327 | 0.030 |
Why?
|
| Lung Volume Measurements | 1 | 1992 | 378 | 0.030 |
Why?
|
| Kidney | 1 | 2007 | 7186 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2018 | 2649 | 0.020 |
Why?
|
| Asbestosis | 1 | 2011 | 82 | 0.020 |
Why?
|
| Radiography, Thoracic | 1 | 2018 | 1265 | 0.020 |
Why?
|
| Molecular Weight | 2 | 1984 | 2255 | 0.020 |
Why?
|
| Catheter Ablation | 1 | 2005 | 2758 | 0.020 |
Why?
|
| Analysis of Variance | 2 | 2013 | 6365 | 0.020 |
Why?
|
| Technetium | 2 | 1999 | 334 | 0.020 |
Why?
|
| Blotting, Western | 1 | 1999 | 5179 | 0.020 |
Why?
|
| Oxidation-Reduction | 3 | 2011 | 2187 | 0.020 |
Why?
|
| Microdissection | 1 | 2011 | 152 | 0.020 |
Why?
|
| Liver Neoplasms, Experimental | 2 | 1983 | 191 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2003 | 9849 | 0.020 |
Why?
|
| Carcinoma 256, Walker | 1 | 1970 | 39 | 0.020 |
Why?
|
| Silver | 1 | 2011 | 122 | 0.020 |
Why?
|
| Byssinosis | 1 | 1990 | 36 | 0.020 |
Why?
|
| Chest Pain | 1 | 2018 | 1114 | 0.020 |
Why?
|
| Gossypium | 1 | 1990 | 36 | 0.020 |
Why?
|
| Antifungal Agents | 1 | 1995 | 730 | 0.020 |
Why?
|
| Base Sequence | 4 | 1996 | 12797 | 0.020 |
Why?
|
| Adaptation, Physiological | 1 | 1997 | 1312 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2018 | 20129 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2011 | 19905 | 0.020 |
Why?
|
| Nitric Oxide | 1 | 1999 | 2132 | 0.020 |
Why?
|
| Genes, Tumor Suppressor | 1 | 1995 | 1097 | 0.020 |
Why?
|
| Dyspnea | 1 | 2018 | 1303 | 0.020 |
Why?
|
| Cobalt | 1 | 1990 | 158 | 0.020 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2018 | 1581 | 0.020 |
Why?
|
| Autopsy | 5 | 1987 | 1020 | 0.020 |
Why?
|
| Stress, Physiological | 1 | 1997 | 1403 | 0.020 |
Why?
|
| Ferric Compounds | 1 | 2011 | 374 | 0.020 |
Why?
|
| Rosette Formation | 1 | 1989 | 153 | 0.020 |
Why?
|
| Acute Disease | 1 | 2000 | 7149 | 0.020 |
Why?
|
| Luminescent Measurements | 1 | 2011 | 405 | 0.020 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2003 | 3047 | 0.020 |
Why?
|
| Diagnosis, Differential | 2 | 2018 | 12959 | 0.020 |
Why?
|
| Receptors, Complement 3b | 1 | 1989 | 145 | 0.020 |
Why?
|
| Molecular Sequence Data | 4 | 1996 | 18111 | 0.020 |
Why?
|
| Lipopolysaccharides | 4 | 1999 | 2216 | 0.020 |
Why?
|
| Neoplasm Metastasis | 2 | 2015 | 4851 | 0.020 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2018 | 2109 | 0.020 |
Why?
|
| Protein Kinase C | 1 | 1993 | 1227 | 0.020 |
Why?
|
| Receptors, Complement | 1 | 1989 | 264 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 1995 | 1869 | 0.020 |
Why?
|
| Immunochemistry | 2 | 1985 | 124 | 0.020 |
Why?
|
| Cytosine | 1 | 2009 | 216 | 0.020 |
Why?
|
| Prognosis | 6 | 2011 | 29063 | 0.020 |
Why?
|
| Treatment Outcome | 4 | 2011 | 63114 | 0.020 |
Why?
|
| Phosphorylation | 1 | 1999 | 8436 | 0.020 |
Why?
|
| Endotoxins | 1 | 1990 | 527 | 0.020 |
Why?
|
| Histocompatibility Antigens | 1 | 1989 | 471 | 0.020 |
Why?
|
| Methacholine Compounds | 1 | 1987 | 35 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 3 | 1995 | 1681 | 0.020 |
Why?
|
| Guinea Pigs | 2 | 1992 | 1386 | 0.020 |
Why?
|
| Airway Obstruction | 1 | 1992 | 664 | 0.020 |
Why?
|
| Pancreatic Elastase | 1 | 1987 | 136 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 1995 | 1889 | 0.020 |
Why?
|
| Lasers | 1 | 2011 | 952 | 0.020 |
Why?
|
| Glutathione Reductase | 1 | 2006 | 25 | 0.020 |
Why?
|
| Organ Culture Techniques | 1 | 1989 | 813 | 0.020 |
Why?
|
| Cell Movement | 1 | 1999 | 5217 | 0.020 |
Why?
|
| Radiotherapy | 1 | 2013 | 1533 | 0.020 |
Why?
|
| Feasibility Studies | 2 | 2007 | 5078 | 0.020 |
Why?
|
| Developmental Disabilities | 1 | 2014 | 1456 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 2 | 2006 | 6386 | 0.020 |
Why?
|
| Antigens, Differentiation | 1 | 1989 | 927 | 0.020 |
Why?
|
| Epidemiologic Methods | 1 | 2011 | 1364 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2012 | 8428 | 0.020 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2011 | 1770 | 0.020 |
Why?
|
| Young Adult | 3 | 2018 | 56430 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2018 | 3597 | 0.020 |
Why?
|
| Testicular Neoplasms | 2 | 1989 | 804 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2001 | 9239 | 0.020 |
Why?
|
| Coronary Disease | 1 | 2000 | 6077 | 0.020 |
Why?
|
| Glutathione Peroxidase | 1 | 2006 | 255 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2014 | 6459 | 0.020 |
Why?
|
| Bronchopneumonia | 2 | 1982 | 11 | 0.020 |
Why?
|
| Body Weight | 3 | 2005 | 4669 | 0.020 |
Why?
|
| Organ Size | 3 | 2005 | 2252 | 0.020 |
Why?
|
| Calcium | 3 | 1993 | 5756 | 0.020 |
Why?
|
| Lung Abscess | 2 | 1982 | 42 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 3 | 1991 | 11524 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2006 | 23338 | 0.020 |
Why?
|
| Electrophoresis | 1 | 2004 | 240 | 0.010 |
Why?
|
| Respiratory Tract Neoplasms | 1 | 1984 | 57 | 0.010 |
Why?
|
| Solitary Pulmonary Nodule | 1 | 1987 | 266 | 0.010 |
Why?
|
| Histological Techniques | 1 | 2004 | 198 | 0.010 |
Why?
|
| Biotransformation | 1 | 1984 | 168 | 0.010 |
Why?
|
| Technetium Tc 99m Sulfur Colloid | 1 | 1983 | 66 | 0.010 |
Why?
|
| Cities | 1 | 2006 | 513 | 0.010 |
Why?
|
| Flow Cytometry | 4 | 1990 | 5974 | 0.010 |
Why?
|
| Ascitic Fluid | 1 | 1984 | 192 | 0.010 |
Why?
|
| Nitrogen Dioxide | 1 | 2006 | 490 | 0.010 |
Why?
|
| Indium | 1 | 1983 | 46 | 0.010 |
Why?
|
| Superoxide Dismutase | 1 | 2006 | 597 | 0.010 |
Why?
|
| Coronary Artery Disease | 1 | 2003 | 6487 | 0.010 |
Why?
|
| Hematologic Tests | 1 | 2004 | 240 | 0.010 |
Why?
|
| Macrophage Activation | 1 | 1986 | 558 | 0.010 |
Why?
|
| Sulfur | 1 | 1983 | 166 | 0.010 |
Why?
|
| Sex Factors | 2 | 2011 | 10397 | 0.010 |
Why?
|
| Lymphatic Metastasis | 2 | 1998 | 2924 | 0.010 |
Why?
|
| Rats, Inbred F344 | 1 | 1984 | 862 | 0.010 |
Why?
|
| Cell Separation | 1 | 1988 | 1751 | 0.010 |
Why?
|
| Cell Line | 4 | 1999 | 15997 | 0.010 |
Why?
|
| Mitral Valve Stenosis | 1 | 1985 | 376 | 0.010 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2011 | 3479 | 0.010 |
Why?
|
| DNA Primers | 2 | 1998 | 2892 | 0.010 |
Why?
|
| Adolescent | 3 | 2018 | 85781 | 0.010 |
Why?
|
| Leukocytes | 1 | 1970 | 2043 | 0.010 |
Why?
|
| Disposable Equipment | 1 | 1981 | 43 | 0.010 |
Why?
|
| Predictive Value of Tests | 2 | 2013 | 15076 | 0.010 |
Why?
|
| Skin | 1 | 1995 | 4364 | 0.010 |
Why?
|
| Bedding and Linens | 1 | 1981 | 41 | 0.010 |
Why?
|
| Fixatives | 2 | 1995 | 94 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2003 | 10943 | 0.010 |
Why?
|
| Thorax | 1 | 2005 | 547 | 0.010 |
Why?
|
| Radionuclide Imaging | 2 | 1983 | 2031 | 0.010 |
Why?
|
| Carbohydrates | 1 | 1984 | 394 | 0.010 |
Why?
|
| Radioisotopes | 1 | 1983 | 499 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 1995 | 5021 | 0.010 |
Why?
|
| Disease Progression | 1 | 2018 | 13284 | 0.010 |
Why?
|
| Clothing | 1 | 1981 | 92 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1984 | 1801 | 0.010 |
Why?
|
| Homozygote | 1 | 2006 | 1785 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 2005 | 1901 | 0.010 |
Why?
|
| Cardiovascular System | 1 | 2008 | 832 | 0.010 |
Why?
|
| Electric Impedance | 1 | 2005 | 729 | 0.010 |
Why?
|
| Carcinoid Tumor | 1 | 1982 | 235 | 0.010 |
Why?
|
| Antimycin A | 2 | 1990 | 30 | 0.010 |
Why?
|
| Survival Rate | 2 | 2008 | 12788 | 0.010 |
Why?
|
| Cushing Syndrome | 1 | 1982 | 249 | 0.010 |
Why?
|
| Tissue Adhesions | 1 | 1981 | 235 | 0.010 |
Why?
|
| Rats, Inbred Strains | 1 | 1981 | 2186 | 0.010 |
Why?
|
| Bronchial Provocation Tests | 2 | 1992 | 227 | 0.010 |
Why?
|
| Neoadjuvant Therapy | 1 | 2011 | 2728 | 0.010 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 1984 | 1369 | 0.010 |
Why?
|
| Hematopoietic Stem Cells | 1 | 1972 | 3386 | 0.010 |
Why?
|
| Osteolysis | 1 | 2001 | 270 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1984 | 2505 | 0.010 |
Why?
|
| BRCA1 Protein | 1 | 2006 | 1149 | 0.010 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 1999 | 192 | 0.010 |
Why?
|
| Equipment Design | 1 | 2007 | 3582 | 0.010 |
Why?
|
| Airway Resistance | 2 | 1992 | 404 | 0.010 |
Why?
|
| Alleles | 1 | 2010 | 6933 | 0.010 |
Why?
|
| Interleukin-2 | 1 | 1986 | 1904 | 0.010 |
Why?
|
| Enterobacteriaceae Infections | 1 | 1980 | 187 | 0.010 |
Why?
|
| Research Support as Topic | 1 | 2003 | 705 | 0.010 |
Why?
|
| Leukemia, Myeloid | 1 | 1982 | 707 | 0.010 |
Why?
|
| Patient Selection | 1 | 2011 | 4215 | 0.010 |
Why?
|
| Karnofsky Performance Status | 1 | 1998 | 173 | 0.010 |
Why?
|
| rac GTP-Binding Proteins | 1 | 1999 | 164 | 0.010 |
Why?
|
| Knee Prosthesis | 1 | 2001 | 425 | 0.010 |
Why?
|
| Radiography | 3 | 1991 | 7023 | 0.010 |
Why?
|
| Contractile Proteins | 1 | 1999 | 246 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 1986 | 3206 | 0.010 |
Why?
|
| Rabbits | 1 | 1984 | 4894 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1984 | 3870 | 0.010 |
Why?
|
| Hyaline Membrane Disease | 1 | 1976 | 19 | 0.010 |
Why?
|
| Nasal Cavity | 1 | 1999 | 313 | 0.010 |
Why?
|
| Dimethyl Sulfoxide | 1 | 1998 | 249 | 0.010 |
Why?
|
| Quality of Life | 1 | 2018 | 12804 | 0.010 |
Why?
|
| Chemokine CCL3 | 1 | 1996 | 83 | 0.010 |
Why?
|
| Sebum | 1 | 1995 | 16 | 0.010 |
Why?
|
| Cycloheximide | 1 | 1996 | 347 | 0.010 |
Why?
|
| Sebaceous Glands | 1 | 1995 | 41 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2018 | 35421 | 0.010 |
Why?
|
| Diaphragm | 1 | 1997 | 349 | 0.010 |
Why?
|
| Sweat Glands | 1 | 1995 | 31 | 0.010 |
Why?
|
| Sweat | 1 | 1995 | 49 | 0.010 |
Why?
|
| Pulmonary Gas Exchange | 1 | 1997 | 382 | 0.010 |
Why?
|
| Microscopy, Immunoelectron | 1 | 1995 | 319 | 0.010 |
Why?
|
| Kinetics | 2 | 1996 | 6473 | 0.010 |
Why?
|
| Genes, ras | 1 | 1998 | 690 | 0.010 |
Why?
|
| Hip Prosthesis | 1 | 2001 | 917 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2012 | 16689 | 0.010 |
Why?
|
| Sulfates | 1 | 1976 | 390 | 0.010 |
Why?
|
| Muscle, Smooth | 1 | 1999 | 934 | 0.010 |
Why?
|
| Swine | 1 | 2005 | 5917 | 0.010 |
Why?
|
| Growth Inhibitors | 1 | 1996 | 385 | 0.010 |
Why?
|
| Mucociliary Clearance | 1 | 1994 | 67 | 0.010 |
Why?
|
| Research | 1 | 2003 | 1999 | 0.010 |
Why?
|
| GTP-Binding Proteins | 1 | 1999 | 970 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 2 | 1995 | 6171 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 1995 | 803 | 0.010 |
Why?
|
| Cell Nucleus | 2 | 1996 | 2969 | 0.010 |
Why?
|
| Inclusion Bodies | 1 | 1995 | 279 | 0.010 |
Why?
|
| Half-Life | 1 | 1995 | 661 | 0.010 |
Why?
|
| Heart Failure | 1 | 2018 | 10900 | 0.010 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 1999 | 1107 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2010 | 9438 | 0.010 |
Why?
|
| Hypertension, Pulmonary | 1 | 1985 | 1537 | 0.010 |
Why?
|
| Actins | 1 | 2001 | 2121 | 0.010 |
Why?
|
| Age Factors | 1 | 2011 | 18370 | 0.010 |
Why?
|
| Asthma | 1 | 1992 | 6011 | 0.010 |
Why?
|
| Data Collection | 1 | 2003 | 3341 | 0.010 |
Why?
|
| Vitamin K | 1 | 1996 | 295 | 0.010 |
Why?
|
| Spectrum Analysis | 1 | 1995 | 454 | 0.010 |
Why?
|
| Microfilament Proteins | 1 | 1999 | 1152 | 0.010 |
Why?
|
| Pregnancy | 1 | 2014 | 29144 | 0.010 |
Why?
|
| Mitochondria | 3 | 1990 | 3520 | 0.010 |
Why?
|
| Solubility | 1 | 1994 | 1085 | 0.010 |
Why?
|
| Infant | 1 | 2014 | 35136 | 0.010 |
Why?
|
| Chemokine CXCL1 | 1 | 1992 | 101 | 0.010 |
Why?
|
| Lipids | 1 | 1984 | 3305 | 0.010 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 1972 | 329 | 0.010 |
Why?
|
| Gene Library | 1 | 1995 | 1074 | 0.010 |
Why?
|
| Capillaries | 1 | 1995 | 773 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2014 | 41006 | 0.010 |
Why?
|
| Liposomes | 1 | 1995 | 759 | 0.010 |
Why?
|
| Biopsy | 3 | 1995 | 6756 | 0.010 |
Why?
|
| Open Reading Frames | 1 | 1995 | 810 | 0.010 |
Why?
|
| Mortality | 1 | 2003 | 2864 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 1999 | 1678 | 0.010 |
Why?
|
| Immunoblotting | 1 | 1995 | 1682 | 0.010 |
Why?
|
| Interleukins | 1 | 1996 | 791 | 0.010 |
Why?
|
| Keratinocytes | 1 | 1995 | 798 | 0.010 |
Why?
|
| Retinoblastoma Protein | 1 | 1995 | 704 | 0.010 |
Why?
|
| Skin Window Technique | 1 | 1970 | 22 | 0.010 |
Why?
|
| Chemokines, CXC | 1 | 1992 | 422 | 0.010 |
Why?
|
| Eicosanoids | 1 | 1992 | 279 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2010 | 15519 | 0.010 |
Why?
|
| Cryopreservation | 1 | 1995 | 670 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1995 | 2839 | 0.010 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 1970 | 115 | 0.010 |
Why?
|
| Retrospective Studies | 5 | 2001 | 77449 | 0.010 |
Why?
|
| Phenanthridines | 1 | 1990 | 51 | 0.010 |
Why?
|
| Extraembryonic Membranes | 1 | 1970 | 41 | 0.010 |
Why?
|
| NF-kappa B | 1 | 1999 | 2499 | 0.010 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2006 | 4034 | 0.010 |
Why?
|
| Public Health | 1 | 2003 | 2603 | 0.010 |
Why?
|
| Signal Transduction | 1 | 1993 | 23403 | 0.010 |
Why?
|
| Fluoresceins | 1 | 1990 | 235 | 0.010 |
Why?
|
| Pseudopodia | 1 | 1970 | 172 | 0.010 |
Why?
|
| Metabolic Clearance Rate | 1 | 1990 | 380 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 1972 | 1827 | 0.010 |
Why?
|
| Leucovorin | 1 | 1991 | 628 | 0.010 |
Why?
|
| Incidence | 1 | 2008 | 20947 | 0.010 |
Why?
|
| Air | 2 | 1982 | 182 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1995 | 4320 | 0.010 |
Why?
|
| Vincristine | 1 | 1991 | 1039 | 0.010 |
Why?
|
| Drug Synergism | 2 | 1984 | 1792 | 0.010 |
Why?
|
| Convalescence | 1 | 1969 | 105 | 0.010 |
Why?
|
| Infectious Mononucleosis | 1 | 1969 | 131 | 0.010 |
Why?
|
| Colony-Forming Units Assay | 1 | 1988 | 356 | 0.000 |
Why?
|
| Chick Embryo | 1 | 1970 | 982 | 0.000 |
Why?
|
| T-Lymphocytes | 1 | 1986 | 10180 | 0.000 |
Why?
|
| Recombinant Proteins | 1 | 1998 | 6622 | 0.000 |
Why?
|
| Administration, Oral | 1 | 1995 | 3913 | 0.000 |
Why?
|
| Methacholine Chloride | 1 | 1987 | 233 | 0.000 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 1982 | 3523 | 0.000 |
Why?
|
| Collagen | 1 | 1995 | 2689 | 0.000 |
Why?
|
| Lymphocyte Activation | 1 | 1998 | 5524 | 0.000 |
Why?
|
| Dermoid Cyst | 1 | 1987 | 93 | 0.000 |
Why?
|
| Prednisone | 1 | 1991 | 1574 | 0.000 |
Why?
|
| Follow-Up Studies | 1 | 2008 | 39050 | 0.000 |
Why?
|
| Latex | 1 | 1986 | 52 | 0.000 |
Why?
|
| Staphylococcal Protein A | 1 | 1985 | 40 | 0.000 |
Why?
|
| Antigen-Antibody Reactions | 1 | 1986 | 363 | 0.000 |
Why?
|
| Vinblastine | 1 | 1987 | 502 | 0.000 |
Why?
|
| Cytoplasm | 1 | 1970 | 1539 | 0.000 |
Why?
|
| Cyclophosphamide | 1 | 1991 | 2242 | 0.000 |
Why?
|
| Mucus | 1 | 1987 | 321 | 0.000 |
Why?
|
| Survival Analysis | 1 | 1998 | 10252 | 0.000 |
Why?
|
| Doxorubicin | 1 | 1991 | 2234 | 0.000 |
Why?
|
| Methotrexate | 1 | 1991 | 1727 | 0.000 |
Why?
|
| Bone Marrow Transplantation | 1 | 1972 | 2765 | 0.000 |
Why?
|
| Endoplasmic Reticulum | 1 | 1970 | 1144 | 0.000 |
Why?
|
| Proportional Hazards Models | 1 | 1999 | 12354 | 0.000 |
Why?
|
| Dexamethasone | 1 | 1991 | 1951 | 0.000 |
Why?
|
| Cell Survival | 2 | 1985 | 5882 | 0.000 |
Why?
|
| Transplantation, Homologous | 1 | 1972 | 4776 | 0.000 |
Why?
|
| Rats, Inbred ACI | 1 | 1983 | 44 | 0.000 |
Why?
|
| Lethal Dose 50 | 1 | 1982 | 77 | 0.000 |
Why?
|
| Amino Acid Sequence | 1 | 1995 | 13815 | 0.000 |
Why?
|
| Hyperbaric Oxygenation | 1 | 1983 | 163 | 0.000 |
Why?
|
| Hormones, Ectopic | 1 | 1982 | 40 | 0.000 |
Why?
|
| Therapeutic Irrigation | 1 | 1984 | 301 | 0.000 |
Why?
|
| Cold Temperature | 1 | 1985 | 772 | 0.000 |
Why?
|
| Gold | 1 | 1985 | 484 | 0.000 |
Why?
|
| Exudates and Transudates | 1 | 1982 | 172 | 0.000 |
Why?
|
| Transcription, Genetic | 1 | 1996 | 7722 | 0.000 |
Why?
|
| Neoplasm Regression, Spontaneous | 1 | 1981 | 46 | 0.000 |
Why?
|
| Castration | 1 | 1981 | 159 | 0.000 |
Why?
|
| Transplantation, Isogeneic | 1 | 1981 | 257 | 0.000 |
Why?
|
| Cisplatin | 1 | 1987 | 1662 | 0.000 |
Why?
|
| Species Specificity | 1 | 1985 | 2478 | 0.000 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 1987 | 934 | 0.000 |
Why?
|
| Organ Specificity | 1 | 1985 | 2008 | 0.000 |
Why?
|
| Lysosomes | 1 | 1985 | 893 | 0.000 |
Why?
|
| Monocytes | 1 | 1990 | 2596 | 0.000 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 1982 | 648 | 0.000 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 1982 | 367 | 0.000 |
Why?
|
| Adrenal Glands | 1 | 1982 | 546 | 0.000 |
Why?
|
| Postoperative Period | 1 | 1985 | 1842 | 0.000 |
Why?
|
| Protein Kinase Inhibitors | 1 | 1995 | 5535 | 0.000 |
Why?
|
| Vasculitis | 1 | 1982 | 519 | 0.000 |
Why?
|
| Necrosis | 1 | 1982 | 1643 | 0.000 |
Why?
|
| Proteins | 1 | 1992 | 6103 | 0.000 |
Why?
|
| Neoplasm Transplantation | 1 | 1981 | 2085 | 0.000 |
Why?
|
| Neutropenia | 1 | 1982 | 895 | 0.000 |
Why?
|
| Autoanalysis | 1 | 1976 | 72 | 0.000 |
Why?
|
| Vascular Diseases | 1 | 1985 | 1161 | 0.000 |
Why?
|
| Heart Valve Prosthesis | 1 | 1985 | 1488 | 0.000 |
Why?
|
| Color | 1 | 1976 | 307 | 0.000 |
Why?
|
| Severity of Illness Index | 1 | 1992 | 15540 | 0.000 |
Why?
|
| Bilirubin | 1 | 1976 | 425 | 0.000 |
Why?
|
| Cross Infection | 1 | 1982 | 1416 | 0.000 |
Why?
|
| Drug Therapy, Combination | 1 | 1982 | 6489 | 0.000 |
Why?
|
| Hemorrhage | 1 | 1982 | 3461 | 0.000 |
Why?
|
| DNA | 1 | 1984 | 7301 | 0.000 |
Why?
|
| Splenomegaly | 1 | 1969 | 190 | 0.000 |
Why?
|
| Fatigue | 1 | 1969 | 1531 | 0.000 |
Why?
|
| Infant, Newborn | 1 | 1976 | 25625 | 0.000 |
Why?
|